4.5 Article Proceedings Paper

Immunity to influenza in the elderly

Journal

VACCINE
Volume 18, Issue 16, Pages 1686-1689

Publisher

ELSEVIER SCI LTD
DOI: 10.1016/S0264-410X(99)00507-1

Keywords

influenza; humans; elderly

Funding

  1. NCI NIH HHS [CA-21765] Funding Source: Medline
  2. NIAID NIH HHS [AI95357] Funding Source: Medline
  3. PHS HHS [A129680] Funding Source: Medline

Ask authors/readers for more resources

influenza is caused by a constantly varying segmented RNA virus that necessitates yearly review of vaccine composition. Humans over the age of 65 years are considered at high risk from influenza; during influenza epidemics the rate of hospitalization in the elderly is very high and up to 90% mortality can occur. Vaccination of the elderly has been shown to be efficacious and cost effective but immunological senescence in the institutionally confined frail elderly is demonstrated by failure to induce herd immunity after vaccination. Reductions in B- and T-cell immunity and in levels of interleukin-2 are age related. Attempts to increase the immunoresponsiveness of the elderly to influenza vaccines have given mixed results. The most convincing evidence is in rodents where dietary caloric restriction has been shown to enhance viral immunity. (C) 2000 Elsevier Science Ltd. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available